Multi-Agent Topical Hair-Loss Formulation for Efficacy and Scalp Comfort

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current hair loss treatments, such as minoxidil and cyoctol, have limited efficacy and cause adverse dermatological reactions, require frequent application, and result in undesirable side effects like drying and irritation, failing to provide healthy-looking hair and scalp.

Innovation Solution

A topical formulation comprising therapeutically effective amounts of azelaic acid, minoxidil, finasteride, and dutasteride, optionally with caffeine and saw palmetto extract, to treat hair loss and promote hair growth, minimizing side effects and application frequency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional anti-alopecia agents like minoxidil and cyoctol are used, then hair loss treatment is provided, but efficacy is limited and adverse dermatological reactions occur

Engineering Contradiction:
Improvetreatment efficacyVSAvoidadverse dermatological reactions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent combines multiple anti-alopecia agents (minoxidil, cyoctol, finasteride, dutasteride) into a single topical formulation. This merging approach allows synergistic effects to enhance treatment efficacy while reducing the need for multiple separate applications, thereby minimizing cumulative adverse reactions from individual agents.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The formulation uses a composite structure containing four distinct anti-alopecia agents with different mechanisms of action. This composite approach allows the treatment to address multiple pathways of hair loss simultaneously, improving overall efficacy while distributing the potential side effects across different mechanisms rather than relying on a single agent.

Inventive Principle:
Principle #40Composite materials

2Device complexity

If single agent formulations are used, then treatment is simplified, but efficacy is limited in many subjects

Engineering Contradiction:
Improveformulation complexityVSAvoidtreatment efficacy
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent merges four different anti-alopecia agents into one unified topical formulation. This combination approach maintains relative simplicity in application (single product, single application) while dramatically improving efficacy by targeting multiple mechanisms of hair loss simultaneously, thus resolving the contradiction between simplicity and effectiveness.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If topical formulations are applied two or more times in 24 hours, then treatment coverage is improved, but user frustration and error increase due to missed applications

Engineering Contradiction:
Improvetreatment coverageVSAvoidapplication frequency
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent combines multiple active agents into a single formulation that can be applied once daily, eliminating the need for multiple separate applications. This merging strategy maintains comprehensive treatment coverage while significantly improving ease of use and compliance by reducing the application schedule to a single daily application.

Inventive Principle:
Principle #5Merging (Combining)

4Reliability

If conventional formulations are applied, then hair loss treatment is provided, but undesirable side effects occur such as drying hair and scalp, frizzing, itching, and extended wet time

Engineering Contradiction:
Improvehair loss treatmentVSAvoidcosmetic side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces carrier agents and formulation excipients that act as intermediaries between the active anti-alopecia agents and the scalp/hair. These intermediaries facilitate the delivery of therapeutic compounds while simultaneously providing cosmetic benefits such as reduced drying, minimized frizzing, and improved scalp comfort, thus resolving the contradiction between treatment efficacy and cosmetic side effects.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12377099B2Methods and compositions to increase hair growth and/or prevent hair loss
Publication Date: 2025.08.05 ATTAIN HEALTH INC
  • US12377099B2 patent drawing

AI summary

In one aspect, the disclosure relates to topical formulations, methods of making same, and methods of treating hair loss using same. In an aspect, the present disclosure pertains to topical formulations for treatment of hair loss and/or to increase hair growth, the formulation comprising: a therapeutic composition comprising therapeutically effective amounts of azelaic acid, minoxidil, finasteride, and dutasteride; and one or more compounding agents. In a further aspect, the present disclosure pertains to a method of treating hair loss by applying a disclosed topical formulation. In a further aspect, the present disclosure pertains to a method of enhancing hair grow by applying a disclosed topical formulation. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.